Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by longonMJon Nov 04, 2018 2:40am
179 Views
Post# 28920573

RE:RE:Revenue forecast

RE:RE:Revenue forecast Well, from looking at those numbers below, those looks like the actuals for Q3 ($21.7M) and Q4 ($22.8) of 2018, and not the forecasted numbers.  With Q1 of the 2019 fiscal year sales coming in at only $25.9M, it looks like Canopy is going to have to really ramp up their sales if they hope to have any chance at all of hitting their forecasted sales target of over $350M for their 2019 full-year.

This basically means they are going to have to do an average of over $100M in total sales for each of their remaining 3 quarters.  This would appear to be a pretty tough task considering the constant talk of store closures and empty shelves due to lack of supply.  After all, if you don't have any product for your customers to buy, guess what your sales revenues will be?

Looks like Canopy will not be alone here in terms of this uphill climb to meet their sales target for the year, as I believe all of the other leading MJcompanies will also be in the same boat. For example, even though Aurora's most recent quarter indicates their sales at about a 25% clip higher than Canopy's, it looks like Aurora's sales target for their 2019 FY is set for over $400M, or about $50M more than Canopy 2019 FY target.

Wonder who's going to come closer to hitting their target and which one will come out on top in terms of total sales revenue for 2019, even though their year-ends are off by a few months from each other.

Walkingzombie1 wrote: Q3 and Q4 2018 has already ended. Q3 2018 ended on Dec 31, 2017 and Q4 2018 ended on Mar 31, 2018.

WEED is now in its 2019 fiscal year. Q1/2019 and Q2/2019 ended on Jun30 and Sep 30, 2018 respectively. Q2/2019 results will be released Nov 14. I don't know what Q3/2018 and Q4/2018 you were talking about. Maybe you are referring to Calendar Q3 and Q4 2018? If so, I think the revenue for those 2 Q will be much higher than $22 or $23 million.

Fiscal year 2019 for WEED started on April 1, 2018 and ends on Mar 31, 2019.   

MNK3240 wrote: In Constellation deal document, Canopy’s revenue forecast for Q3/2018 and Q4/2018 were $22m and $23m respectively. Even they do way better than forecasts, that’s not gonna do anything. If there is a run up before and after earnings, that has to be guidance and partnerships or other things not by revenue or profitability, guaranteed.

At this point, stock price has to go up based on potential not because of performance that will take time.




Bullboard Posts